Switzerland

Switzerland

View Profile →

Switzerland-Singapore Bilateral Trade Analysis 2023

Complete trade statistics: $11.57B total volume •Switzerland surplus: $3.67B

SwitzerlandSingapore

$7.62B

Exports (2023)

SingaporeSwitzerland

$3.95B

Imports (2023)

Trade Balance

$3.67B

Surplus for Switzerland

Total Trade

$11.57B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Switzerland and Singapore. Green line shows exports from Switzerland, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Switzerland-Singapore commercial relationship and competitive positioning in global markets.

SwitzerlandSingapore Exports

$7.62B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
18.7% top product
1Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$1.43B
18.7% of exports
2Metals: gold, semi-manufactured
$982.04M
12.9% of exports
3Metals: gold, non-monetary, unwrought (but not powder)
$873.37M
11.5% of exports
4Wrist-watches: (not electrically operated), automatic winding, whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$765.61M
10.1% of exports
5Wrist-watches: whether or not incorporating a stop-watch facility, with automatic winding
$718.10M
9.4% of exports
6Jewellery: of precious metal (excluding silver) whether or not plated or clad with precious metal, and parts thereof
$510.54M
6.7% of exports
7Heterocyclic compounds: n.e.c. in headings no. 2933
$344.45M
4.5% of exports
8Wrist-watches: (not electrically operated), (not automatic winding), whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$188.54M
2.5% of exports
9Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$132.63M
1.7% of exports
10Wrist-watches: electrically operated, with or without a stop-watch, (other than those of heading no. 9101) with mechanical display only
$96.94M
1.3% of exports

🎯 Strategic Export Focus

Switzerland's export portfolio to Singapore demonstrates strong diversification across multiple sectors, with heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5 representing a key competitive advantage in this bilateral market.

SingaporeSwitzerland Imports

$3.95B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
47.3% concentration
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$1.87B
47.3% of imports
2Metals: gold, non-monetary, unwrought (but not powder)
$611.70M
15.5% of imports
3Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
$320.64M
8.1% of imports
4Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$300.99M
7.6% of imports
5Jewellery: of precious metal (excluding silver) whether or not plated or clad with precious metal, and parts thereof
$152.73M
3.9% of imports
6Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale
$131.50M
3.3% of imports
7Wrist-watches: (not electrically operated), automatic winding, whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$45.26M
1.1% of imports
8Surveying equipment: theodolites and tacheometers
$41.14M
1.0% of imports
9Wrist-watches: electrically operated, with or without a stop-watch, with case of precious metal or of metal clad with precious metal, with mechanical display only
$24.45M
0.6% of imports
10Wrist-watches: (not electrically operated), (not automatic winding), whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$24.09M
0.6% of imports

📦 Import Strategy Analysis

Switzerland's import pattern from Singapore reveals significant dependencyin medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

🏆

Market Leadership

Switzerland demonstrates competitive strength in exportingheterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5 to Singapore, leveraging comparative advantages.

Export Leader in 20+ Categories
🔄

Trade Complementarity

The bilateral relationship showsmoderatecomplementarity, with each country specializing in different sectors.

Specialized Exchange
📈

Growth Potential

The $11.57B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Switzerland-Singapore Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $11.57 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Switzerland maintains a surplus of $3.67 billion
  • Export Focus: Switzerland's primary exports include heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5, metals: gold, semi-manufactured, metals: gold, non-monetary, unwrought (but not powder)
  • Import Dependencies: Key imports from Singapore include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, metals: gold, non-monetary, unwrought (but not powder), blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthImbalanced

📈 Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $11.57B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Switzerland leveraging its comparative advantages in heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Switzerland's specialization in heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5complements Singapore's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $11.57B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyHigh
🔮

Trade Relationship Outlook

The $11.57B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

💰

Trade Volume Impact

The $11.57 billion bilateral trade volume represents a significant economic factorfor both economies.

Economic Significance: High
🏭

Industrial Integration

Trade flows in heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5 and medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
⚖️

Trade Balance Effects

Switzerland's trade surplus of $3.67 billion strengthens its overall economic position in this bilateral relationship.

Balance Impact: Export Advantage

Strategic Future Outlook

🚀Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in metals: gold, semi-manufactured present expansion opportunities.
Market Diversification
Beyond current focus on medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, new product categories offer potential for trade expansion.

⚠️Risk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5 may affect future market positioning.

🎯Strategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Switzerland and Singapore represents a total trade volume of $11.57 billion in 2023. This partnership demonstrates a favorable trade balance for Switzerland, with exports exceeding importsby $3.67 billion.

Export Strengths

Switzerland's exports to Singapore total $7.62 billion, with competitive advantages in heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5, representing $1.43B or18.7% of bilateral exports.

Import Dependencies

Imports from Singapore amount to $3.95 billion, highlighting economic interdependence in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale comprising47.3% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Switzerland's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Switzerland and Singapore in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023